Intranasal Esketamine and the Dawn of Precision Psychiatry

Overview

Journal Braz J Psychiatry

Specialty Psychiatry

Date 2021 Jul 28

PMID 34320126

Citations 1

Authors

Devon Watts

Frederico D Garcia

Acioly L T Lacerda

Jair de J Mari

Lucas C Quarantini

Flavio Kapczinski

Affiliations

Soon will be listed here.

Citing Articles

Not only pharmacodynamic: the role of brain circuits in improving the treatment of suicidal thoughts and behaviors.

Damiano R, Miguel E, Shephard E Braz J Psychiatry. 2022; 44(1):113.

PMID: 35170674 PMC: 8827373. DOI: 10.1590/1516-4446-2021-2257.

References

Kennedy S, Lam R, McIntyre R, Tourjman S, Bhat V, Blier P . Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016; 61(9):540-60. PMC: 4994790. DOI: 10.1177/0706743716659417. View

Hyman S . Psychiatric drug development: diagnosing a crisis. Cerebrum. 2013; 2013:5. PMC: 3662213. View

Daly E, Singh J, Fedgchin M, Cooper K, Lim P, Shelton R . Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2017; 75(2):139-148. PMC: 5838571. DOI: 10.1001/jamapsychiatry.2017.3739. View

Phillips J, Norris S, Talbot J, Hatchard T, Ortiz A, Birmingham M . Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology. 2019; 45(4):606-612. PMC: 7021716. DOI: 10.1038/s41386-019-0570-x. View

Krystal J, Sanacora G, Duman R . Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry. 2013; 73(12):1133-41. PMC: 3671489. DOI: 10.1016/j.biopsych.2013.03.026. View

Gelenberg A, Chesen C . How fast are antidepressants?. J Clin Psychiatry. 2000; 61(10):712-21. DOI: 10.4088/jcp.v61n1002. View

Berlim M, Turecki G . Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry. 2007; 52(1):46-54. DOI: 10.1177/070674370705200108. View

Milak M, Rashid R, Dong Z, Kegeles L, Grunebaum M, Ogden R . Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial. JAMA Netw Open. 2020; 3(8):e2013211. PMC: 7424409. DOI: 10.1001/jamanetworkopen.2020.13211. View

Rush A, Trivedi M, Wisniewski S, Nierenberg A, Stewart J, Warden D . Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163(11):1905-17. DOI: 10.1176/ajp.2006.163.11.1905. View

10.

Zanos P, Gould T . Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018; 23(4):801-811. PMC: 5999402. DOI: 10.1038/mp.2017.255. View

11.

Krystal J, Abdallah C, Sanacora G, Charney D, Duman R . Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron. 2019; 101(5):774-778. PMC: 6560624. DOI: 10.1016/j.neuron.2019.02.005. View

12.

Phillips J, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A . Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. Am J Psychiatry. 2019; 176(5):401-409. DOI: 10.1176/appi.ajp.2018.18070834. View

13.

Wang D, Penna A, Orser B . Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons. Anesthesiology. 2016; 126(4):666-677. DOI: 10.1097/ALN.0000000000001483. View

14.

Passos I, Ballester P, Rabelo-da-Ponte F, Kapczinski F . Precision Psychiatry: The Future Is Now. Can J Psychiatry. 2021; 67(1):21-25. PMC: 8807995. DOI: 10.1177/0706743721998044. View

15.

Merikangas K, Jin R, He J, Kessler R, Lee S, Sampson N . Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011; 68(3):241-51. PMC: 3486639. DOI: 10.1001/archgenpsychiatry.2011.12. View

16.

Steel Z, Marnane C, Iranpour C, Chey T, Jackson J, Patel V . The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014; 43(2):476-93. PMC: 3997379. DOI: 10.1093/ije/dyu038. View

17.

Duman R, Sanacora G, Krystal J . Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments. Neuron. 2019; 102(1):75-90. PMC: 6450409. DOI: 10.1016/j.neuron.2019.03.013. View

18.

Correia-Melo F, Leal G, Vieira F, Jesus-Nunes A, Mello R, Magnavita G . Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study. J Affect Disord. 2019; 264:527-534. DOI: 10.1016/j.jad.2019.11.086. View